CLINICAL_TRIALS
trial_result
· 2012-10-29
Clinical Trial Update: Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa [Phase 4]
Summary
Phase 4 trial evaluating epoetin alfa for subarachnoid hemorrhage. The study was terminated and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of South Florida | Conditions: Subarachnoid Hemorrhage | Phase 4 | Status: TERMINATED | Results posted: 2012-10-29